Skip to main content
Erschienen in: Der Pathologe 5/2015

01.09.2015 | Schwerpunkt: Histiozytäre Erkrankungen

Die pulmonale Langerhans-Zell-Histiozytose

verfasst von: Univ.-Prof. Dr. H.H. Popper

Erschienen in: Die Pathologie | Ausgabe 5/2015

Einloggen, um Zugang zu erhalten

Zusammenfassung

Die pulmonale Langerhans-Zell-Histiozytose kann als reaktive Proliferation von Langerhans-Zellen auf chronischen Tabakrauchkonsum gesehen werden, kann aber auch besonders im Kindesalter als eine tumorartige systemische Erkrankung auftreten. Morphologisch können diese beiden Formen derzeit nicht unterschieden werden. In den Lungen kommt es zu einer nodulären Proliferation von Langerhans-Zellen in der Bronchialmukosa, aber auch peripher in den Alveolarsepten mit einer begleitenden Infiltration durch eosinophile Granulozyten und Zerstörung der Bronchialwand. Die Langerhans-Zellen lassen sich selektiv mithilfe von Antikörpern auf CD1a und Langerin nachweisen. In der reaktiven isoliert pulmonalen Form führt die Abstinenz von Tabakrauch bei den meisten Patienten zu einer Regression der Infiltrate und einer Besserung der Symptome. Radiologisch sind auch nach völliger Tabakrauchabstinenz die kleinen sternförmigen Narben zu erkennen.
Literatur
1.
Zurück zum Zitat Ackerman AJ (1947) Eosinophilic granuloma of bones associated with involvement of the lungs and diaphragm. Am J Roentgenol Radium Ther 58(6):733–740PubMed Ackerman AJ (1947) Eosinophilic granuloma of bones associated with involvement of the lungs and diaphragm. Am J Roentgenol Radium Ther 58(6):733–740PubMed
3.
4.
Zurück zum Zitat Nadeau PJ, Ellis FH Jr, Harrison EG Jr, Fontana RS (1960) Primary pulmonary histiocytosis X. Dis Chest 37:325–339PubMedCrossRef Nadeau PJ, Ellis FH Jr, Harrison EG Jr, Fontana RS (1960) Primary pulmonary histiocytosis X. Dis Chest 37:325–339PubMedCrossRef
5.
Zurück zum Zitat Weiss W, Johnston DG (1957) Pulmonary histiocytosis X. Am Rev Tuberc 75(2):319–325PubMed Weiss W, Johnston DG (1957) Pulmonary histiocytosis X. Am Rev Tuberc 75(2):319–325PubMed
6.
Zurück zum Zitat Friedman PJ, Liebow AA, Sokoloff J (1981) Eosinophilic granuloma of lung. Clinical aspects of primary histiocytosis in the adult. Medicine (Baltimore) 60(6):385–396CrossRef Friedman PJ, Liebow AA, Sokoloff J (1981) Eosinophilic granuloma of lung. Clinical aspects of primary histiocytosis in the adult. Medicine (Baltimore) 60(6):385–396CrossRef
7.
Zurück zum Zitat Knudson RJ, Badger TL, Gaensler EA (1966) Eosinophilic granuloma of the lung. Med Thorac 23(4):248–262PubMed Knudson RJ, Badger TL, Gaensler EA (1966) Eosinophilic granuloma of the lung. Med Thorac 23(4):248–262PubMed
8.
Zurück zum Zitat Lichtenstein L (1964) Histiocytosis X (Eosinophilic Granuloma of Bone, Letterer-Siwe Disease, and Schueller-Christian Disease). Further observations of pathological and clinical importance. J Bone Joint Surg Am 46:76–90PubMed Lichtenstein L (1964) Histiocytosis X (Eosinophilic Granuloma of Bone, Letterer-Siwe Disease, and Schueller-Christian Disease). Further observations of pathological and clinical importance. J Bone Joint Surg Am 46:76–90PubMed
9.
Zurück zum Zitat Cline MJ (1994) Histiocytes and histiocytosis. Blood 84(9):2840–2853PubMed Cline MJ (1994) Histiocytes and histiocytosis. Blood 84(9):2840–2853PubMed
10.
Zurück zum Zitat Nezelof C, Basset F (1998) Langerhans cell histiocytosis research. Past, present, and future. Hematol Oncol Clin North Am 12(2):385–406PubMedCrossRef Nezelof C, Basset F (1998) Langerhans cell histiocytosis research. Past, present, and future. Hematol Oncol Clin North Am 12(2):385–406PubMedCrossRef
11.
Zurück zum Zitat Chikwava KR, Hunt JL, Mantha GS, Murphy JE, Jaffe R (2007) Analysis of loss of heterozygosity in single-system and multisystem Langerhans’ cell histiocytosis. Pediatr Dev Pathol 10(1):18–24PubMedCrossRef Chikwava KR, Hunt JL, Mantha GS, Murphy JE, Jaffe R (2007) Analysis of loss of heterozygosity in single-system and multisystem Langerhans’ cell histiocytosis. Pediatr Dev Pathol 10(1):18–24PubMedCrossRef
12.
13.
Zurück zum Zitat van Nieuwenhuijze AE, Coghill E, Gray D et al (2014) Transgenic expression of GM-CSF in T cells causes disseminated histiocytosis. Am J Pathol 184(1):184–199PubMedCrossRef van Nieuwenhuijze AE, Coghill E, Gray D et al (2014) Transgenic expression of GM-CSF in T cells causes disseminated histiocytosis. Am J Pathol 184(1):184–199PubMedCrossRef
14.
Zurück zum Zitat Chilosi M, Facchetti F, Calio A et al (2014) Oncogene-induced senescence distinguishes indolent from aggressive forms of pulmonary and non-pulmonary Langerhans cell histiocytosis. Leuk Lymphoma 55(11):2620–2626PubMedCrossRef Chilosi M, Facchetti F, Calio A et al (2014) Oncogene-induced senescence distinguishes indolent from aggressive forms of pulmonary and non-pulmonary Langerhans cell histiocytosis. Leuk Lymphoma 55(11):2620–2626PubMedCrossRef
15.
Zurück zum Zitat Sundar KM, Gosselin MV, Chung HL, Cahill BC (2003) Pulmonary Langerhans cell histiocytosis: emerging concepts in pathobiology, radiology, and clinical evolution of disease. Chest 123(5):1673–1683PubMedCrossRef Sundar KM, Gosselin MV, Chung HL, Cahill BC (2003) Pulmonary Langerhans cell histiocytosis: emerging concepts in pathobiology, radiology, and clinical evolution of disease. Chest 123(5):1673–1683PubMedCrossRef
16.
Zurück zum Zitat Attili AK, Kazerooni EA, Gross BH et al (2008) Smoking-related interstitial lung disease: radiologic-clinical-pathologic correlation. Radiographics 28(5):1383–1396 (discussion 96–98)PubMedCrossRef Attili AK, Kazerooni EA, Gross BH et al (2008) Smoking-related interstitial lung disease: radiologic-clinical-pathologic correlation. Radiographics 28(5):1383–1396 (discussion 96–98)PubMedCrossRef
18.
Zurück zum Zitat Egeler RM, Favara BE, van Meurs M, Laman JD, Claassen E (1999) Differential In situ cytokine profiles of Langerhans-like cells and T cells in Langerhans cell histiocytosis: abundant expression of cytokines relevant to disease and treatment. Blood 94(12):4195–4201PubMed Egeler RM, Favara BE, van Meurs M, Laman JD, Claassen E (1999) Differential In situ cytokine profiles of Langerhans-like cells and T cells in Langerhans cell histiocytosis: abundant expression of cytokines relevant to disease and treatment. Blood 94(12):4195–4201PubMed
19.
Zurück zum Zitat Uebelhoer M, Bewig B, Sternberg K et al (1995) Alveolar macrophages from bronchoalveolar lavage of patients with pulmonary histiocytosis X: determination of phenotypic and functional changes. Lung 173(3):187–195PubMedCrossRef Uebelhoer M, Bewig B, Sternberg K et al (1995) Alveolar macrophages from bronchoalveolar lavage of patients with pulmonary histiocytosis X: determination of phenotypic and functional changes. Lung 173(3):187–195PubMedCrossRef
20.
Zurück zum Zitat Costabel U, Guzman J, Bonella F, Oshimo S (2007) Bronchoalveolar lavage in other interstitial lung diseases. Semin Respir Crit Care Med 28(5):514–524PubMedCrossRef Costabel U, Guzman J, Bonella F, Oshimo S (2007) Bronchoalveolar lavage in other interstitial lung diseases. Semin Respir Crit Care Med 28(5):514–524PubMedCrossRef
21.
Zurück zum Zitat Dziegiel P, Dolilnska-Krajewska B, Dumanska M et al (2007) Coexpression of CD1a, langerin and Birbeck’s granules in Langerhans cell histiocytoses (LCH) in children: ultrastructural and immunocytochemical studies. Folia Histochem Cytobiol 45(1):21–25PubMed Dziegiel P, Dolilnska-Krajewska B, Dumanska M et al (2007) Coexpression of CD1a, langerin and Birbeck’s granules in Langerhans cell histiocytoses (LCH) in children: ultrastructural and immunocytochemical studies. Folia Histochem Cytobiol 45(1):21–25PubMed
22.
Zurück zum Zitat Wilejto M, Abla O (2012) Langerhans cell histiocytosis and Erdheim-Chester disease. Curr Opin Rheumatol 24(1):90–96PubMedCrossRef Wilejto M, Abla O (2012) Langerhans cell histiocytosis and Erdheim-Chester disease. Curr Opin Rheumatol 24(1):90–96PubMedCrossRef
23.
Zurück zum Zitat Badalian-Very G, Vergilio JA, Degar BA, Rodriguez-Galindo C, Rollins BJ (2012) Recent advances in the understanding of Langerhans cell histiocytosis. Br J Haematol 156(2):163–172PubMedCrossRef Badalian-Very G, Vergilio JA, Degar BA, Rodriguez-Galindo C, Rollins BJ (2012) Recent advances in the understanding of Langerhans cell histiocytosis. Br J Haematol 156(2):163–172PubMedCrossRef
24.
Zurück zum Zitat Routy B, Hoang J, Gruber J (2015) Pulmonary langerhans cell histiocytosis with lytic bone involvement in an adult smoker: regression following smoking cessation. Case Rep Hematol 2015:201536PubMedCentralPubMed Routy B, Hoang J, Gruber J (2015) Pulmonary langerhans cell histiocytosis with lytic bone involvement in an adult smoker: regression following smoking cessation. Case Rep Hematol 2015:201536PubMedCentralPubMed
25.
Zurück zum Zitat Yousem SA, Dacic S, Nikiforov YE, Nikiforova M (2013) Pulmonary Langerhans cell histiocytosis: profiling of multifocal tumors using next-generation sequencing identifies concordant occurrence of BRAF V600E mutations. Chest 143(6):1679–1984PubMedCrossRef Yousem SA, Dacic S, Nikiforov YE, Nikiforova M (2013) Pulmonary Langerhans cell histiocytosis: profiling of multifocal tumors using next-generation sequencing identifies concordant occurrence of BRAF V600E mutations. Chest 143(6):1679–1984PubMedCrossRef
26.
Zurück zum Zitat Roden AC, Hu X, Kip S et al (2014) BRAF V600E expression in Langerhans cell histiocytosis: clinical and immunohistochemical study on 25 pulmonary and 54 extrapulmonary cases. Am J Surg Pathol 38(4):548–551PubMedCrossRef Roden AC, Hu X, Kip S et al (2014) BRAF V600E expression in Langerhans cell histiocytosis: clinical and immunohistochemical study on 25 pulmonary and 54 extrapulmonary cases. Am J Surg Pathol 38(4):548–551PubMedCrossRef
27.
Zurück zum Zitat Shahla A, Parvaneh V, Hossein HD (2004) Langerhans cells histiocytosis in one family. Pediatr Hematol Oncol 21(4):313–320PubMedCrossRef Shahla A, Parvaneh V, Hossein HD (2004) Langerhans cells histiocytosis in one family. Pediatr Hematol Oncol 21(4):313–320PubMedCrossRef
28.
Zurück zum Zitat Arceci RJ (2014) Biological and therapeutic implications of the BRAF pathway in histiocytic disorders. Am Soc Clin Oncol Educ Book 2014:e441–e445CrossRef Arceci RJ (2014) Biological and therapeutic implications of the BRAF pathway in histiocytic disorders. Am Soc Clin Oncol Educ Book 2014:e441–e445CrossRef
29.
Zurück zum Zitat Wei R, Wang Z, Li X, Shu Y, Fu B (2013) Frequent mutation has no effect on tumor invasiveness in patients with Langerhans cell histiocytosis. Biomed Rep 1(3):365–368PubMedCentralPubMed Wei R, Wang Z, Li X, Shu Y, Fu B (2013) Frequent mutation has no effect on tumor invasiveness in patients with Langerhans cell histiocytosis. Biomed Rep 1(3):365–368PubMedCentralPubMed
30.
Zurück zum Zitat Hutter C, Kauer M, Simonitsch-Klupp I et al (2012) Notch is active in Langerhans cell histiocytosis and confers pathognomonic features on dendritic cells. Blood 120(26):5199–5208PubMedCrossRef Hutter C, Kauer M, Simonitsch-Klupp I et al (2012) Notch is active in Langerhans cell histiocytosis and confers pathognomonic features on dendritic cells. Blood 120(26):5199–5208PubMedCrossRef
31.
Zurück zum Zitat Murakami I, Morimoto A, Oka T et al (2013) IL-17A receptor expression differs between subclasses of Langerhans cell histiocytosis, which might settle the IL-17A controversy. Virchows Arch 462(2):219–228PubMedCrossRef Murakami I, Morimoto A, Oka T et al (2013) IL-17A receptor expression differs between subclasses of Langerhans cell histiocytosis, which might settle the IL-17A controversy. Virchows Arch 462(2):219–228PubMedCrossRef
32.
Zurück zum Zitat Coury F, Annels N, Rivollier A et al (2008) Langerhans cell histiocytosis reveals a new IL-17A-dependent pathway of dendritic cell fusion. Nat Med 14(1):81–87PubMedCrossRef Coury F, Annels N, Rivollier A et al (2008) Langerhans cell histiocytosis reveals a new IL-17A-dependent pathway of dendritic cell fusion. Nat Med 14(1):81–87PubMedCrossRef
33.
Zurück zum Zitat Nelson DS, van Halteren A, Quispel WT et al (2015) MAP2K1 and MAP3K1 mutations in Langerhans cell histiocytosis. Genes Chromosomes Cancer 54(6):361–368PubMedCrossRef Nelson DS, van Halteren A, Quispel WT et al (2015) MAP2K1 and MAP3K1 mutations in Langerhans cell histiocytosis. Genes Chromosomes Cancer 54(6):361–368PubMedCrossRef
34.
Zurück zum Zitat Kawauchi Y, Kuroda Y, Kojima N (2012) Preferences for uptake of carbohydrate-coated liposomes by C-type lectin receptors as antigen-uptake receptors. Glycoconj J 29(7):481–490PubMedCrossRef Kawauchi Y, Kuroda Y, Kojima N (2012) Preferences for uptake of carbohydrate-coated liposomes by C-type lectin receptors as antigen-uptake receptors. Glycoconj J 29(7):481–490PubMedCrossRef
35.
Zurück zum Zitat Chabrol E, Nurisso A, Daina A et al (2012) Glycosaminoglycans are interactants of Langerin: comparison with gp120 highlights an unexpected calcium-independent binding mode. PLoS One 7(11):e50722PubMedCentralPubMedCrossRef Chabrol E, Nurisso A, Daina A et al (2012) Glycosaminoglycans are interactants of Langerin: comparison with gp120 highlights an unexpected calcium-independent binding mode. PLoS One 7(11):e50722PubMedCentralPubMedCrossRef
36.
Zurück zum Zitat Salazar F, Ghaemmaghami AM (2013) Allergen recognition by innate immune cells: critical role of dendritic and epithelial cells. Front Immunol 4:356PubMedCentralPubMedCrossRef Salazar F, Ghaemmaghami AM (2013) Allergen recognition by innate immune cells: critical role of dendritic and epithelial cells. Front Immunol 4:356PubMedCentralPubMedCrossRef
37.
Zurück zum Zitat Lambrecht BN, Hammad H (2014) Allergens and the airway epithelium response: gateway to allergic sensitization. J Allergy Clin Immunol 134(3):499–507PubMedCrossRef Lambrecht BN, Hammad H (2014) Allergens and the airway epithelium response: gateway to allergic sensitization. J Allergy Clin Immunol 134(3):499–507PubMedCrossRef
38.
Zurück zum Zitat Santiago-Schwarz F (1999) Positive and negative regulation of the myeloid dendritic cell lineage. J Leukoc Biol 66(2):209–216PubMed Santiago-Schwarz F (1999) Positive and negative regulation of the myeloid dendritic cell lineage. J Leukoc Biol 66(2):209–216PubMed
39.
Zurück zum Zitat Bartlett JA, Fischer AJ, McCray PB Jr (2008) Innate immune functions of the airway epithelium. Contrib Microbiol 15:147–163PubMedCrossRef Bartlett JA, Fischer AJ, McCray PB Jr (2008) Innate immune functions of the airway epithelium. Contrib Microbiol 15:147–163PubMedCrossRef
40.
Zurück zum Zitat Karo JM, Sun JC (2015) Novel molecular mechanism for generating NK-cell fitness and memory. Eur J Immunol 45(7):1906–1915PubMedCrossRef Karo JM, Sun JC (2015) Novel molecular mechanism for generating NK-cell fitness and memory. Eur J Immunol 45(7):1906–1915PubMedCrossRef
41.
Zurück zum Zitat Satpathy AT, Chang HY (2015) Long noncoding RNA in hematopoiesis and immunity. Immunity 42(5):792–804PubMedCrossRef Satpathy AT, Chang HY (2015) Long noncoding RNA in hematopoiesis and immunity. Immunity 42(5):792–804PubMedCrossRef
42.
Zurück zum Zitat Haniffa M, Bigley V, Collin M (2015) Human mononuclear phagocyte system reunited. Semin Cell Dev Biol 41:59–69PubMedCrossRef Haniffa M, Bigley V, Collin M (2015) Human mononuclear phagocyte system reunited. Semin Cell Dev Biol 41:59–69PubMedCrossRef
43.
Zurück zum Zitat Fischer A (2015) Recent advances in understanding the pathophysiology of primary T cell immunodeficiencies. Trends Mol Med 21(7):408–416PubMedCrossRef Fischer A (2015) Recent advances in understanding the pathophysiology of primary T cell immunodeficiencies. Trends Mol Med 21(7):408–416PubMedCrossRef
44.
Zurück zum Zitat Egeler RM, van Halteren AG, Hogendoorn PC, Laman JD, Leenen PJ (2010) Langerhans cell histiocytosis: fascinating dynamics of the dendritic cell-macrophage lineage. Immunol Rev 234(1):213–232PubMedCrossRef Egeler RM, van Halteren AG, Hogendoorn PC, Laman JD, Leenen PJ (2010) Langerhans cell histiocytosis: fascinating dynamics of the dendritic cell-macrophage lineage. Immunol Rev 234(1):213–232PubMedCrossRef
45.
Zurück zum Zitat Koethe SM, Kuhnmuench JR, Becker CG (2000) Neutrophil priming by cigarette smoke condensate and a tobacco anti-idiotypic antibody. Am J Pathol 157(5):1735–1743PubMedCentralPubMedCrossRef Koethe SM, Kuhnmuench JR, Becker CG (2000) Neutrophil priming by cigarette smoke condensate and a tobacco anti-idiotypic antibody. Am J Pathol 157(5):1735–1743PubMedCentralPubMedCrossRef
46.
Zurück zum Zitat Youkeles LH, Grizzanti JN, Liao Z, Chang CJ, Rosenstreich DL (1995) Decreased tobacco-glycoprotein-induced lymphocyte proliferation in vitro in pulmonary eosinophilic granuloma. Am J Respir Crit Care Med 151(1):145–150PubMedCrossRef Youkeles LH, Grizzanti JN, Liao Z, Chang CJ, Rosenstreich DL (1995) Decreased tobacco-glycoprotein-induced lymphocyte proliferation in vitro in pulmonary eosinophilic granuloma. Am J Respir Crit Care Med 151(1):145–150PubMedCrossRef
47.
Zurück zum Zitat Popper HH (1999) Epithelioid cell granulomatosis of the lung: new insights and concepts. Sarcoidosis Vasc Diffuse Lung Dis 16(1):32–46PubMed Popper HH (1999) Epithelioid cell granulomatosis of the lung: new insights and concepts. Sarcoidosis Vasc Diffuse Lung Dis 16(1):32–46PubMed
48.
Zurück zum Zitat Fisher GM, Iqball S, Knight SC (1999) Gene expression during differentiation of human dendritic cells from cord blood cd34 stem cells. Cytokine 11(2):111–117PubMedCrossRef Fisher GM, Iqball S, Knight SC (1999) Gene expression during differentiation of human dendritic cells from cord blood cd34 stem cells. Cytokine 11(2):111–117PubMedCrossRef
49.
Zurück zum Zitat Popper HH (2013) Interstitial lung diseases-can pathologists arrive at an etiology-based diagnosis? A critical update. Virchows Arch 462(1):1–26PubMedCrossRef Popper HH (2013) Interstitial lung diseases-can pathologists arrive at an etiology-based diagnosis? A critical update. Virchows Arch 462(1):1–26PubMedCrossRef
50.
Zurück zum Zitat Hyman DM, Diamond EL, Vibat CR et al (2015) Prospective blinded study of BRAFV600E mutation detection in cell-free DNA of patients with systemic histiocytic disorders. Cancer Discov 5(1):64–71PubMedCrossRef Hyman DM, Diamond EL, Vibat CR et al (2015) Prospective blinded study of BRAFV600E mutation detection in cell-free DNA of patients with systemic histiocytic disorders. Cancer Discov 5(1):64–71PubMedCrossRef
51.
52.
Zurück zum Zitat Park HJ, Jeon YK, Lee AH et al (2012) Use of the JL1 epitope, which encompasses the nonglycosylation site of CD43, as a marker of immature/neoplastic Langerhans cells. Am J Surg Pathol 36(8):1150–1117PubMedCrossRef Park HJ, Jeon YK, Lee AH et al (2012) Use of the JL1 epitope, which encompasses the nonglycosylation site of CD43, as a marker of immature/neoplastic Langerhans cells. Am J Surg Pathol 36(8):1150–1117PubMedCrossRef
Metadaten
Titel
Die pulmonale Langerhans-Zell-Histiozytose
verfasst von
Univ.-Prof. Dr. H.H. Popper
Publikationsdatum
01.09.2015
Verlag
Springer Berlin Heidelberg
Erschienen in
Die Pathologie / Ausgabe 5/2015
Print ISSN: 2731-7188
Elektronische ISSN: 2731-7196
DOI
https://doi.org/10.1007/s00292-015-0052-9

Weitere Artikel der Ausgabe 5/2015

Der Pathologe 5/2015 Zur Ausgabe

Schwerpunkt: Histiozytäre Erkrankungen

Histiozytäre Erkrankung des Kindes- und Jugendalters

Mitteilungen des Bundesverbandes Deutscher Pathologen e.V.

Mitteilungen des Bundesverbandes Deutscher Pathologen e.V.

Schwerpunkt: Histiozytäre Erkrankungen

Erdheim-Chester- und Rosai-Dorfman-Erkrankung

CME Zertifizierte Fortbildung

Akute Leukämien des Erwachsenen

Schwerpunkt: Histiozytäre Erkrankungen

Tumorassoziierte Makrophagen

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.